JOSEPH KARPEL: Open Payments
NPI 1861020190 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 41 payments from 16 companies in 2025. Trend: 2023 $4,868 · 2024 $2,531 · 2025 $1,304
Food & beverage: $1,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $210 |
| Abbott Laboratories | 3 | $191 |
| Tandem Diabetes Care, Inc. | 3 | $179 |
| Sequel Med Tech, LLC | 1 | $159 |
| BETA BIONICS, INC. | 5 | $135 |
| Neurocrine BioSciences, Inc. | 1 | $69 |
| Novo Nordisk Inc | 3 | $66 |
| Dexcom, Inc. | 2 | $51 |
| TOLMAR, INC. | 2 | $49 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
Products named: LUPRON DEPOT, FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, TWIIST, iLet Bionic Pancreas, CRENESSITY, Dexcom G6 Transmitter, FENSOLVI.
Industry payments across CA — which companies pay providers there.
